(Q51650310)

English

Health-related quality of life and continuation rate on first-line anti-tumour necrosis factor therapy among rheumatoid arthritis patients from the Australian Rheumatology Association Database.

scientific article published on 7 October 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/20929971

Health-related quality of life and continuation rate on first-line anti-tumour necrosis factor therapy among rheumatoid arthritis patients from the Australian Rheumatology Association Database. (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/20929971

0 references

0 references

quality of life

1 reference

based on heuristic

inferred from title

rheumatoid arthritis

1 reference

based on heuristic

inferred from title

Rachelle Buchbinder

5

object named as

Rachelle Buchbinder

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

author name string

Margaret P Staples

1

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/20929971

Lyn March

2

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/20929971

Marissa Lassere

3

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/20929971

Chris Reid

4

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/20929971

publication date

7 October 2010

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/20929971

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/20929971

50

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/20929971

1

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/20929971

166-175

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/20929971

Efficacy, tolerability and cost effectiveness of disease-modifying antirheumatic drugs and biologic agents in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEQ322

21 January 2018

Patient-reported outcomes in a randomized trial comparing four different treatment strategies in recent-onset rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEQ322

21 January 2018

How antirheumatic drugs protect joints from damage in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEQ322

21 January 2018

Effect of treatment with biological agents for arthritis in Australia: the Australian Rheumatology Association Database.

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEQ322

21 January 2018

Efficacy and safety of abatacept or infliximab vs placebo in ATTEST: a phase III, multi-centre, randomised, double-blind, placebo-controlled study in patients with rheumatoid arthritis and an inadequate response to methotrexate

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEQ322

21 January 2018

The impact of infliximab treatment on quality of life in patients with inflammatory rheumatic diseases

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEQ322

21 January 2018

Patient-reported health outcomes in a trial of etanercept monotherapy versus combination therapy with etanercept and methotrexate for rheumatoid arthritis: the ADORE trial.

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEQ322

21 January 2018

Quality-of-life assessment in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEQ322

21 January 2018

Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEQ322

21 January 2018

Cost-utility analysis of treatment strategies in patients with recent-onset rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEQ322

21 January 2018

Sustained improvement over two years in physical function, structural damage, and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexate

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEQ322

21 January 2018

The effectiveness and medication costs of three anti-tumour necrosis factor alpha agents in the treatment of rheumatoid arthritis from prospective clinical practice data

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEQ322

21 January 2018

Benefit of anti-TNF therapy in rheumatoid arthritis patients with moderate disease activity

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEQ322

21 January 2018

Measurement of patient outcome in arthritis

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEQ322

21 January 2018

The SF36 Version 2: critical analyses of population weights, scoring algorithms and population norms

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEQ322

21 January 2018

Determining minimally important changes in generic and disease-specific health-related quality of life questionnaires in clinical trials of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEQ322

21 January 2018

The Assessment of Quality of Life (AQoL) instrument: a psychometric measure of health-related quality of life

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEQ322

21 January 2018

Population norms and meaningful differences for the Assessment of Quality of Life (AQoL) measure.

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEQ322

21 January 2018

EQ-5D: a measure of health status from the EuroQol Group

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEQ322

21 January 2018

Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D.

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEQ322

21 January 2018

Sociodemographic differences in quality of life in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEQ322

21 January 2018

Change and status in quality of life in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEQ322

21 January 2018

Psychosocial factors, disease status, and quality of life in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEQ322

21 January 2018

The health-related quality of life in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: a comparison with a selected sample of healthy people

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEQ322

21 January 2018

Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEQ322

21 January 2018

Switching TNF antagonists in patients with chronic arthritis: an observational study of 488 patients over a four-year period

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEQ322

21 January 2018

Identifiers

10.1093/RHEUMATOLOGY/KEQ322

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/20929971

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/20929971

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51650310&oldid=1260376029"